PHARM vs PHG: Side-by-Side Comparison
Compare Pharming Group NV (PHARM) and Koninklijke Philips N.V. (PHG) side by side: market cap EUR 829.85M vs USD 26.41B, P/E 83.0 vs 23.8. Financials, growth and model signals on Bullrun.
| Metric | PHARM | PHG |
|---|---|---|
| Company | Pharming Group NV | Koninklijke Philips N.V. |
| Country / Exchange | Netherlands · AS | Netherlands · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
| Market cap | EUR 829.85M | USD 26.41B |
| P/E ratio | 83.0 | 23.8 |
| Dividend yield | — | 3.65% |
| Valuation model | 48.1% overvalued | 10.4% undervalued |
| Revenue (latest FY) | USD 376.13M | — |
| Revenue growth YoY | +26.6% | — |
| Net income | USD 2.54M | — |
| Gross margin | 87.9% | — |
| Diluted EPS | 0.00 | — |